Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

NCT02631577

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University Miami Miami, Florida, United States

Norton Medical Plaza II Louisville, Kentucky, United States

Memorial Sloan-Kettering Cancer Center; Hematology/Oncology New York, United States

View all 16 locations

View Trial Details

Completed

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

NCT02471911

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +14 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

NCT04571567

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Mount Sinai West Dermatolgy New York, United States

View Trial Details

Completed

A Phase I Trial of AZD3965 in Patients With Advanced Cancer

NCT01791595

Conditions: Adult Solid Tumor, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations: Royal Marsden Hospital Sutton, London, United Kingdom

The Beatson West of Scotland, Glasgow Glasgow, United Kingdom

Leicester Royal Infirmary Leicester, United Kingdom

University College London Hospitals London, United Kingdom

View Trial Details

Completed

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05318391

Conditions: Gene Expression Profiling, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Yian Zhang Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

NCT01994382

Conditions: Aggressive NHL (a NHL), B-cell Non Hodgkin Lymphoma (NHL), Bronchial Diseases, +34 more
Locations: Huntsville, Alabama, United States

Gilbert, Arizona, United States

Los Angeles, California, United States

Palo Alto, California, United States

View all 23 locations

View Trial Details

Completed

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

NCT03465527

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Kosin University Gospel Hospital Busan, Sue-gu, South Korea

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

NCT04453384

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +21 more
Locations: CHU Amiens Picardie Amiens, France

CHU Angers Angers, France

Hôpital Privé d'Antony Antony, France

CH Avignon Avignon, France

View all 34 locations

View Trial Details

Completed

T-VEC in Non-melanoma Skin Cancer

NCT03458117

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +31 more
Locations: Department of Dermatology, University Hospital Zurich Zurich, Switzerland

View Trial Details

Completed

CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients

NCT04260932

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hebei Yanda Ludaopei Hospital Sanhe, Hebei, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions